Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Bromodomain containing protein | 0.0076 | 0.0091 | 0.0089 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0025 | 0.0012 | 0.0012 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.6477 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0018 | 0.0002 | 0.0052 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0018 | 0.0002 | 0.0002 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.0012 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.0084 | 0.0084 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.6477 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0039 | 0.0033 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.004 | 0.004 |
Echinococcus granulosus | zinc finger protein | 0.002 | 0.0004 | 0.0004 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.6477 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0006 | 0.0006 |
Toxoplasma gondii | FATC domain-containing protein | 0.0025 | 0.0012 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.6477 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.002 | 0.0004 | 0.0004 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0033 | 0.0033 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0036 | 0.003 | 0.003 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0023 | 0.0009 | 0.0009 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0018 | 0.0002 | 0.0002 |
Schistosoma mansoni | bromodomain containing protein | 0.0064 | 0.0073 | 0.0073 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0025 | 0.0012 | 1 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0018 | 0.0001 | 0.0001 |
Schistosoma mansoni | zinc finger protein | 0.002 | 0.0004 | 0.0004 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0018 | 0.0002 | 0.0002 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0023 | 0.0009 | 0.0009 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0036 | 0.003 | 0.003 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0025 | 0.0012 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0037 | 0.0037 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0021 | 0.0006 | 0.0006 |
Giardia lamblia | GTOR | 0.0018 | 0.0002 | 0.5 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0018 | 0.0002 | 0.0002 |
Echinococcus granulosus | serine protein kinase ATM | 0.0025 | 0.0012 | 0.0012 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0025 | 0.0012 | 0.0012 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0025 | 0.0012 | 0.0011 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0061 | 0.0067 | 0.0067 |
Brugia malayi | PHD-finger family protein | 0.0025 | 0.0012 | 0.0011 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0018 | 0.0002 | 0.0002 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0007 | 0.4849 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0007 | 0.0007 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0018 | 0.0002 | 0.0002 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0023 | 0.0009 | 0.0009 |
Entamoeba histolytica | hypothetical protein | 0.0025 | 0.0012 | 1 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0018 | 0.0002 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0018 | 0.0002 | 0.0002 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0018 | 0.0002 | 0.0002 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0061 | 0.0067 | 0.0067 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.